Evidence strongly suggests a positive outcome in the treatment of atrophic vaginitis, orgasmic dysfunction, stress incontinence and prolapse of the bladder or rectum with ThermiVa
Southlake, TX (PRWEB) May 02, 2015
As a nonsurgical staple in the treatment of skin laxity issues of the face, neck and décolleté, radiofrequency energy is proving to be a new concept with real potential for the success of vulvovaginal rejuvenation. In a pilot study published by the ThermiHealth Clinical Advisory Council, ThermiGyn’s Women’s Health Clinical Advisory Board Chairman Red Alinsod, MD, FACOG, FACS, ACGE, concluded that ThermiGyn’s temperature controlled radio frequency, specifically that of ThermiVa, for vulvovaginal rejuvenation, is safe, tolerable and effective.
“Evidence strongly suggests a positive outcome in the treatment of atrophic vaginitis, orgasmic dysfunction, stress incontinence and prolapse of the bladder or rectum with ThermiVa,” explains Dr. Alinsod. “Further investigation via randomized, controlled trials isolating and exploring various potential indications is more than warranted.”
In the pilot study, Dr. Alinsod focused on 23 patients that underwent ThermiGyn’s nonsurgical treatment, ThermiVa. Dr. Alinsod reported, “After just one treatment, vulvovaginal laxity improved significantly and continued to improve after the third and final treatment. Patients described notable improvement in vaginal moisture, continence and sexual satisfaction and described the experience as pleasant and comfortable.”
“Given the safety, simplicity and ease of treatment associated with TTCRF as well as the remarkable results and high patient satisfaction with virtually no risk, downtime, or discomfort, this novel therapy shows much promise in both the medical and aesthetic arenas in an increasingly accepting social climate,” notes Dr. Alinsod.
For more information, please visit http://www.thermiva.com.
About Red Alinsod, MD
Dr. Red Alinsod graduated from Loma Linda University School of Medicine and completed his OB/GYN residency at Loma Linda University Medical Center. His focus in those early years was pelvic surgery. He was the first Rutledge Fellow at MD Anderson Cancer and Tumor Institute and was also selected as a Galloway Fellow at Memorial Sloan Kettering Medical Center. Dr. Alinsod was accepted to Yale’s Gynecologic Oncology fellowship but was unable to attend due to a military commitment with the US Air Force. He headed the Gynecologic Services at George Air Force Base, CA, and Nellis Air Force Base, NV, as he concentrated on benign gynecology, urogynecology and pelvic surgery.
Dr. Alinsod is instrumental in the development of aesthetic vulvovaginal surgery. He founded "CAVS" (Congress for Aesthetic Vulvovaginal Surgery) in 2005 and is considered one of the pioneers of this evolving field. He is responsible for the current techniques in radiofrequency labiaplasty of the minora, the "Barbie" and Hybrid Look labiaplasty, invented the Medial Curvilinear Labia Majoraplasty, and the central and lateral clitoral hood reductions. He developed the combination Pudenal-Levator Block for In-Office Awake/No IV labiaplasty and vaginoplasty and has taught this technique worldwide. He was also the first surgeon to perform non-invasive labia majora RF skin tightening and RF vaginal canal tightening.
ThermiGyn, a wholly owned subsidiary of ThermiHealth, provides advanced technology using finely controlled thermal energy. The multi-use platform promotes increased patient safety and clinical effectiveness while providing versatile micro-invasive and non-invasive solutions for OB-GYNs serving the womens health marketplace. ThermiVa is a daughter product to the ThermiHealth flagship product, the ThermiRF Temperature Controlled Radio Frequency Generator System, and is FDA cleared for dermatological and general surgical procedures for electrocoagulation and hemostasis; and to create lesions in nervous tissue. ThermiRF is an advanced technology using finely controlled thermal energy. It is a multi-use platform, which promotes increased patient safety and clinical effectiveness while providing versatile solutions for physicians serving the medical and aesthetic market.
For more information about ThermiGyn, please visit http://www.thermi.com.